Abstract
In inflammatory bowel diseases (IBD), risk of thrombosis and production of antibodies are increased. In autoimmune and inflammatory disorders, a role of anti-prothrombin (aPT) antibodies in developing thrombosis has been hypothesised. The aim of the study is to evaluate the prevalence of aPT antibodies in IBD patients, with and without thrombosis.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1281-1286 |
| Numero di pagine | 6 |
| Rivista | International Journal of Colorectal Disease |
| Volume | 28 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- Thrombosis